180 related articles for article (PubMed ID: 19479125)
1. Onychophagia as a spectrum of obsessive-compulsive disorder.
Pacan P; Grzesiak M; Reich A; Szepietowski JC
Acta Derm Venereol; 2009; 89(3):278-80. PubMed ID: 19479125
[TBL] [Abstract][Full Text] [Related]
2. A double-blind comparison of clomipramine and desipramine treatment of severe onychophagia (nail biting).
Leonard HL; Lenane MC; Swedo SE; Rettew DC; Rapoport JL
Arch Gen Psychiatry; 1991 Sep; 48(9):821-7. PubMed ID: 1929772
[TBL] [Abstract][Full Text] [Related]
3. Drug Treatment of Trichotillomania (Hair-Pulling Disorder), Excoriation (Skin-picking) Disorder, and Nail-biting (Onychophagia).
Sani G; Gualtieri I; Paolini M; Bonanni L; Spinazzola E; Maggiora M; Pinzone V; Brugnoli R; Angeletti G; Girardi P; Rapinesi C; Kotzalidis GD
Curr Neuropharmacol; 2019; 17(8):775-786. PubMed ID: 30892151
[TBL] [Abstract][Full Text] [Related]
4. Onychophagia and onychotillomania: prevalence, clinical picture and comorbidities.
Pacan P; Grzesiak M; Reich A; Kantorska-Janiec M; Szepietowski JC
Acta Derm Venereol; 2014 Jan; 94(1):67-71. PubMed ID: 23756561
[TBL] [Abstract][Full Text] [Related]
5. Sertraline: new indication. May help children with obsessive-compulsive disorder.
Prescrire Int; 2002 Jun; 11(59):69-72. PubMed ID: 12068839
[TBL] [Abstract][Full Text] [Related]
6. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
[TBL] [Abstract][Full Text] [Related]
7. Onychophagia is associated with impairment of quality of life.
Pacan P; Reich A; Grzesiak M; Szepietowski JC
Acta Derm Venereol; 2014 Nov; 94(6):703-6. PubMed ID: 24535041
[TBL] [Abstract][Full Text] [Related]
8. Dermatology and conditions related to obsessive-compulsive disorder.
Stein DJ; Hollander E
J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):237-42. PubMed ID: 1552059
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder.
Kumar TC; Khanna S
Aust N Z J Psychiatry; 2000 Jun; 34(3):527-8. PubMed ID: 10881981
[No Abstract] [Full Text] [Related]
10. Onychophagia: A nail-biting conundrum for physicians.
Halteh P; Scher RK; Lipner SR
J Dermatolog Treat; 2017 Mar; 28(2):166-172. PubMed ID: 27387832
[TBL] [Abstract][Full Text] [Related]
11. A review of pharmacologic treatments for obsessive-compulsive disorder.
Kaplan A; Hollander E
Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
[TBL] [Abstract][Full Text] [Related]
12. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
Barr LC; Goodman WK; Anand A; McDougle CJ; Price LH
Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of comorbid obsessive-compulsive and depressive disorders in children age].
Goriunov AV; Lobacheva MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11 Pt 2):48-52. PubMed ID: 23257756
[TBL] [Abstract][Full Text] [Related]
14. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
[TBL] [Abstract][Full Text] [Related]
15. A Hierarchical Personality Approach Toward a Fuller Understanding of Onychophagia and Compulsive Buying.
Rizzo C; Sestino A; Pino G; Guido G; Nataraajan R; Harnish RJ
Psychol Rep; 2023 Jun; 126(3):1322-1338. PubMed ID: 35147062
[TBL] [Abstract][Full Text] [Related]
16. On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
Todorov C; Freeston MH; Borgeat F
Can J Psychiatry; 2000 Apr; 45(3):257-62. PubMed ID: 10779882
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
Greist JH; Jefferson JW; Kobak KA; Katzelnick DJ; Serlin RC
Arch Gen Psychiatry; 1995 Jan; 52(1):53-60. PubMed ID: 7811162
[TBL] [Abstract][Full Text] [Related]
18. Onychophagia as a clinical symptom: A pilot study of physicians and literature review.
Lesinskiene S; Pociute K; Dervinyte-Bongarzoni A; Kinciniene O
Sci Prog; 2021 Oct; 104(4):368504211050288. PubMed ID: 34874802
[TBL] [Abstract][Full Text] [Related]
19. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Pigott TA; Seay SM
J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of clomipramine in obsessive-compulsive disorder.
Howland RH
Anxiety; 1996; 2(1):56-7. PubMed ID: 9160602
[No Abstract] [Full Text] [Related]
[Next] [New Search]
